Correlation Between Alnylam Pharmaceuticals and CannBioRx Life

Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and CannBioRx Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and CannBioRx Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alnylam Pharmaceuticals and CannBioRx Life Sciences, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and CannBioRx Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of CannBioRx Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and CannBioRx Life.

Diversification Opportunities for Alnylam Pharmaceuticals and CannBioRx Life

-0.11

Correlation Coefficient

Alnylam Pharmaceuticals  CannBioRx Life

Good diversification

The 3 months correlation between Alnylam and CannBioRx is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and CannBioRx Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CannBioRx Life Sciences and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with CannBioRx Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CannBioRx Life Sciences has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and CannBioRx Life go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals and CannBioRx Life

Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 25.8 times less return on investment than CannBioRx Life. But when comparing it to its historical volatility, Alnylam Pharmaceuticals is 13.93 times less risky than CannBioRx Life. It trades about 0.06 of its potential returns per unit of risk. CannBioRx Life Sciences is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.85  in CannBioRx Life Sciences on March 14, 2024 and sell it today you would earn a total of  0.57  from holding CannBioRx Life Sciences or generate 67.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Alnylam Pharmaceuticals  vs.  CannBioRx Life Sciences

Alnylam Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Alnylam Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

CannBioRx Life Sciences

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CannBioRx Life Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, CannBioRx Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alnylam Pharmaceuticals and CannBioRx Life

The main advantage of trading using opposite Alnylam Pharmaceuticals and CannBioRx Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, CannBioRx Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CannBioRx Life will offset losses from the drop in CannBioRx Life's long position.

The idea behind Alnylam Pharmaceuticals and CannBioRx Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.